Figure 1From: Radiation dose ≥54 Gy and CA 19–9 response are associated with improved survival for unresectable, non-metastatic pancreatic cancer treated with chemoradiationOverall survival for patients treated with < or ≥ 54 Gy of radiotherapy. Note: two long term survivors are censored at 58 and 88 months.Back to article page